AZACITIDINE Spirig HC subst seche pdr 100 mg 1 pce

7680682730018 CH-68273 L01BC07 07.16.1.

Active substances:

AZACITIDINE Spirig HC subst seche pdr 100 mg 1 pce
AZACITIDINE Spirig HC subst seche pdr 100 mg 1 pce
AZACITIDINE Spirig HC subst seche pdr 100 mg 1 pce
1 / 3
google

Details

Product number
6827301
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
azacitidinum 100 mg, mannitolum, pro vitro.

Articles (1)

Azacitidin Spirig HC 100 mg, Pulver zur Herstellung einer Injektionssuspension
Pulver zur Herstellung einer Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
14/01/2025
Professional SmPC
Français
14/01/2025
Professional SmPC
Italien
14/01/2025

Detailed composition

Substance Quantity Type Category
azacitidinum
100.0 MG Substance Wirkstoff (Principe actif)
mannitolum
- Substance HNIDK

Reimbursement information

Public price
CHF 259.95
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2021

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68273
Drug name
Azacitidin Spirig HC, Pulver zur Herstellung einer Injektionssuspension
Galenic form
PULVS
ATC Code
L01BC07
Authorization status
Z
Dispensation category
A
First authorization
15/02/2021
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Packaging details

Description (FR)
AZACITIDINE Spirig HC subst seche pdr 100 mg 1 pce
Description (DE)
AZACITIDIN Spirig HC Trockensub 100 mg 1 Stk
Market launch
15/02/2021
Narcotic (BTM)
No

Original drug

Vidaza, Lyophilisat zur Herstellung einer Injektionssuspension
CHF 350.75
View original
Buy us a coffee Explore the data